CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

banner


> Publications

> 1993 Publications

 

1. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.
Srivastava S, Wang S, Tong YA, Pirollo KF and Chang EH.
Oncogene. 8:2449-2445, 1993.
2. Dominant negative effect a germ-line mutant p53: A step fostering tumorigenesis.
Srivastava S, Wang S, Tong YA, Hao Z-M and Chang EH
Cancer Research. 53:4452-55, 1993.
3. Bilateral synchronous testis tumor: mixed germ cell tumor and the ca cell tumor.
Schenkman N, Ho CK, and Moul JW:
Urology 42:593-95, 1993.
4. Retroperitoneal lymphadenectomy (letter).
Moul JW:
Canadian J. Surg., 36:16 1993.
5. Gangrene of the penis after implantation of penile prosthesis: Case reports, treatment recommendations and review of the literature.
Moul JW:
Editorial comments: J Urol, 150: 190-2, 1993.
6. Prostatitis: sorting out the different causes.
Moul JW:
Postgrad Med 94(5):191-94, 1993.
7. James Claude Kimbrough: The Father of Modern US Army Urology.
Moul JW:
Mil Med 158:213-22, 1993.
8. Long-term results with vacuum constriction device.
Moul JW:
Editorial comments to: J Urol. 149:290-94, 1993.
9. Active chemotherapy for metastatic stromal cell tumor of the testis.
Moul JW:
Editorial comments: Urology, 42:734, 1993.
10. Benign prostatic hyperplasia: new concepts in the 1990's.
Moul JW:
Postgrad Med. 94(6):141-52, 1993.
11. Tortuous and aberrant external iliac artery precluding radical retropubic prostatectomy for prostate cancer.
Moul JW, Wind GG, and Wright CR:
Urology 42:450-52, 1993.
12. Flow cytometric and quantitative histological parameters to predict occult disease in clinical stage I nonseminomatous testicular cancer.
Moul JW, Foley JP, Hitchcock CL, Becker RL, McCarthy WF, Sesterhenn IA, and Griffin JL:
J Urol 150:879-883, 1993.
13. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas.
Moul JW, Bishoff JT, Theune SM, and Chang EH:
J Urol 149:1389-94, 1993.
14. Expression of the c-erbB-2 oncoprotein in prostate cancer.
Kuhn EJ, Kurnot RA, Sesterhenn IA, Chang EH, and Moul JW:
J Urol 150:1427-33, 1993.
15. Altered mRNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF and Zou ZQ.
Cancer Research. 53:1889-1894, 1993.
Back to Top
Disclaimer | © 2005 CPDR. All Rights Reserved.